Content about Citrates

November 12, 2012
FDA approves Watson PAH drug

The Food and Drug Administration has approved a generic drug for pulmonary arterial hypertension made by Watson Pharmaceuticals, the drug maker said Monday.

PARSIPPANY, N.J. — The Food and Drug Administration has approved a generic drug for pulmonary arterial hypertension made by Watson Pharmaceuticals, the drug maker said Monday.

Watson said the FDA approved its sildenafil tablets in the 20 mg strength through a subsidiary. Watson said it would launch the drug "in the near future."

The drug is a generic version of Pfizer's Revatio tablets, which had sales of about $339 million during the 12-month period ended in September, according to IMS Health.

October 3, 2012
Sagent launches drug for apnea of prematurity in infants

Sagent Pharmaceuticals has launched a drug used to treat apnea of prematurity in infants, the drug maker said Wednesday.

SCHAUMBURG, Ill. — Sagent Pharmaceuticals has launched a drug used to treat apnea of prematurity in infants, the drug maker said Wednesday.

Sagent announced the launch of caffeine citrate injection and caffeine citrate oral solution, used to treat apnea of prematurity in infants between 28 and less than 33 weeks gestational age.

The market for the drug was worth about $28.5 million during the 12-month period ended in July, according to IMS Health. The drug features Sagent's PreventIV Measures packaging and labeling, which are designed to reduce medication errors.

December 23, 2011
Research: Viagra being studied for heart benefits

According to research to be published in the journal Circulation released Friday, sildenafil, the active ingredient in Viagra, can help alleviate heart problems.

QUERENBURG, Germany — According to research to be published in the journal Circulation released Friday, sildenafil, the active ingredient in Viagra, can help alleviate heart problems.

The research was conducted in collaboration with the Mayo Clinic in Rochester, Minn.

August 31, 2011
Star Scientific launches immune system booster

Star Scientific on Tuesday launched Anatabloc, a dietary supplement formulated to support the immune system.

GLEN ALLEN, Va. — Star Scientific on Tuesday launched Anatabloc, a dietary supplement formulated to support the immune system.

Anatabloc contains the dietary ingredient anatabine citrate, an alkaloid found in a variety of plants in the Solanaceae family, including the tobacco plant, as well as in eggplant, green peppers and green tomatoes. Anatabine citrate, combined with vitamins A and D3, is believed to assist the body in maintaining anti-inflammatory support, the company stated.

August 15, 2011
Viagra patent upheld

Pfizer announced that the patent for its popular erectile dysfunction treatment was upheld in court.

NEW YORK — Pfizer announced that the patent for its popular erectile dysfunction treatment was upheld in court.

The drug maker said that the U.S. District Court for the Eastern District of Virginia concluded that Pfizer's patent for Viagra was valid and enforceable and prevents generic drug maker Teva from marketing its version of the drug until October 2019. Pfizer noted that litigation on the same patent remains pending against other generic companies, but no trials are scheduled in those other cases.

The court's decision, however, is subject to appeal by Teva.

July 21, 2011
FDA OKs REMS for Fentora, Actiq

The Food and Drug Administration has approved a risk evaluation and mitigation strategy for two painkillers made by Cephalon, the drug maker said Thursday.

FRAZER, Pa. — The Food and Drug Administration has approved a risk evaluation and mitigation strategy for two painkillers made by Cephalon, the drug maker said Thursday.

The FDA approved a REMS for Fentora (fentanyl) buccal tablets and Actiq (oral transmucosal fentanyl citrate). Both drugs are used for managing breakthrough pain in cancer patients who have become tolerant of opioid drugs.

June 7, 2011
Global Wellness recalls lots of Via Extreme supplement due to presence of undeclared drug

Global Wellness on Tuesday initiated a voluntary nationwide recall of its Via Extreme ultimate sexual enhancer dietary supplement for men.

HOLLYWOOD, Fla. — Global Wellness on Tuesday initiated a voluntary nationwide recall of its Via Extreme ultimate sexual enhancer dietary supplement for men.

The product — a bottle containing six blue-colored capsules per package — was distributed throughout the United States, Puerto Rico and Canada to Internet and retail consumers, the company reported.

Global Wellness is recalling only lots 809013 and 806030; the recall does not affect sales and distribution of Slim Extreme Gold and Gelslim, the company stated.

April 14, 2011
Report: Drug makers look to create new erectile dysfunction treatments

Drug manufacturers are coming up with new versions of their drugs for erectile dysfunction as those drugs’ loss of patent protection and subsequent generic competition draw near, according to published reports.

NEW YORK — Drug manufacturers are coming up with new versions of their drugs for erectile dysfunction as those drugs’ loss of patent protection and subsequent generic competition draw near, according to published reports.

February 15, 2011
Report: Rxs for Viagra, Cialis get boost from Valentine's Day

It shouldn’t surprise people too much, but pills to treat male impotence tend to see big increases in prescriptions around Valentine’s Day, according to published reports.

NEW YORK — It shouldn’t surprise people too much, but pills to treat male impotence tend to see big increases in prescriptions around Valentine’s Day, according to published reports.

Bloomberg reported that prescriptions of such drugs as Pfizer’s Viagra (sildenafil) and Eli Lilly’s Cialis (tadalafil) are at their highest in the days leading up to the holiday.

November 18, 2010
FDA issues warning over use of dietary supplements containing sildenafil

The Food and Drug Administration on Friday reported that Vigor-25, a product inappropriately marketed as...

SILVER SPRING, Md. — The Food and Drug Administration on Friday reported that Vigor-25, a product inappropriately marketed as a natural dietary supplement to enhance male sexual performance, should not be purchased or used because it contains sildenafil, the active ingredient in the prescription drug Viagra.

 

August 12, 2010
Prolatis recalls male-enhancement product

Prolatis earlier this week announced a voluntary nationwide recall of the company’s product sold under...

SALT LAKE CITY Prolatis earlier this week announced a voluntary nationwide recall of the company’s product sold under the brand name Prolatis’ after being informed by the Food and Drug Administration that lab analysis has found their male-enhancement products to contain sulfoaildenafil, an analogue of sildenafil, an FDA-approved drug used as treatment for male erectile dysfunction.

 

That makes Prolatis’ an unapproved drug, as opposed to a dietary supplement.